Lensar Inc, Orlando, Fla, recently announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for a suite of five new application technologies integrated into its Lensar laser system. The system will be on display at the American Society of Cataract and Refractive Surgery annual meeting April 18–20, 2015, at the San Diego Convention Center.

The Lensar laser system with Streamline is a femtosecond laser cataract platform that enables automation of several surgical procedure planning and execution elements. Upgrades include wireless integration with the company’s Cassini corneal shape analyzer, iris registration, cataract density imaging, customized fragmentation patterns, and arcuate incision planning.

The latest updates provide surgeons with access to an arcuate incision planning table that includes parameters to define the location, depth, and extent of the intended arcuate incisions based on individual patient biometric measurements and other surgeon-defined factors. The integrated cataract density imaging automatically categorizes the cataract to a preprogrammed, surgeon-customized fragmentation pattern depending upon the density of the cataract. This allows the surgeon to automatically isolate fragmentation to the nucleus, which could have a positive impact on efficiency and procedure time.

“Lensar has given the reigns to the surgeon to make the laser-assisted refractive cataract procedure customized to both patient and surgeon needs,” said Robert Weinstock, MD, director of cataract and refractive services at the Eye Institute of West Florida and the Weinstock Laser Eye Center. “The ability to preprogram the laser just one time with a surgeon’s specific preferences may increase the efficiency and accuracy for every procedure thereafter, enhancing patient comfort and, ultimately, visual outcomes.”

Streamline upgrades, including the arcuate incision planning, cataract density imaging, and customized fragmentation patterns, will be made available to all Lensar users. The full Streamline technology suite will be available to practices currently using both the Lensar laser system and the Cassini corneal shape analyzer.